KBC Group
AMPH icon

KBC Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

KBC Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,159
Closed -$63K – 1719
2025
Q1 		$63K Hold
2,159
– – ﹤0.01% 1718
2024
Q4 		$80K Buy
2,159
+650
+43% +$29.7K ﹤0.01% 1677
2024
Q3 		$73K Hold
1,509
– – ﹤0.01% 1490
2024
Q2 		$60K Buy
1,509
+538
+55% +$22.3K ﹤0.01% 1507
2024
Q1 		$43K Hold
971
– – ﹤0.01% 1629
2023
Q4 		$60K Sell
971
-131
-12% -$6.88K ﹤0.01% 1385
2023
Q3 		$51K Sell
1,102
-1,668
-60% -$91K ﹤0.01% 1426
2023
Q2 		$159K Sell
2,770
-408
-13% -$18.1K ﹤0.01% 1010
2023
Q1 		$119K Hold
3,178
– – ﹤0.01% 1149
2022
Q4 		$89K Hold
3,178
– – ﹤0.01% 1247
2022
Q3 		$89K Hold
3,178
– – ﹤0.01% 1229
2022
Q2 		$111K Buy
+3,178
New +$113K ﹤0.01% 1189
2020
Q1 		– Sell
-42,019
Closed -$811K – 1287
2019
Q4 		$811K Hold
42,019
– – 0.01% 956
2019
Q3 		$833K Hold
42,019
– – 0.01% 930
2019
Q2 		$887K Sell
42,019
-13,588
-24% -$284K 0.01% 891
2019
Q1 		$1.14M Hold
55,607
– – 0.01% 820
2018
Q4 		$1.11M Sell
55,607
-16,046
-22% -$316K 0.01% 717
2018
Q3 		$1.38M Buy
71,653
+7,782
+12% +$139K 0.01% 812
2018
Q2 		$975K Buy
63,871
+2,630
+4% +$46K 0.01% 814
2018
Q1 		$1.15M Buy
61,241
+15,225
+33% +$286K 0.01% 735
2017
Q4 		$885K Hold
46,016
– – 0.01% 841
2017
Q3 		$822K Hold
46,016
– – 0.01% 858
2017
Q2 		$822K Hold
46,016
– – 0.01% 840
2017
Q1 		$667K Buy
46,016
+16,460
+56% +$259K 0.01% 982
2016
Q4 		$544K Buy
+29,556
New +$575K 0.01% 1014

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KBC Group's AMPH Position: Q2 2025 in Review

KBC Group sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 2,159 shares — an estimated $63K sold.

KBC Group first reported a position in AMPH in Q4 2016 and held it in 25 quarters. The position peaked at $1.38M in Q3 2018. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • KBC Group reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • KBC Group sold 2,159 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $63K.
  • KBC Group first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 25 quarters.
  • KBC Group's Amphastar Pharmaceuticals position peaked at $1.38M in Q3 2018.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.